期刊文献+

体外受精一胚胎移植中三种不同的促排方法临床疗效和经济性的比较分析 被引量:3

Comparison of clinical efficacy and cost-effectiveness of IVF-ET cycles with three different protocols of controlled ovarian hyperstimulation
下载PDF
导出
摘要 目的比较体外受精-胚胎移植(IVF-ET)控制性超排卵(COH)中三种不同促排卵方法的疗效及经济性。方法回顾性分析2012年1~12月在我院生殖中心行IVF/卵胞浆内单精子注射(ICSI)常规长方案治疗的不孕症患者共242个治疗周期,根据COH中不同促排方法分为三组,重组卵泡刺激素组(rFSH,果纳芬)102例,高纯度尿源性卵泡刺激素组(uFSH,丽申宝)82例,高纯度尿源性卵泡刺激素+人绝经期促性腺激素(uFSH+HMG)58例。比较三组患者促性腺激素(Gn)用量、Gn天数、人绒毛膜促性腺激素(HCG)注射日雌二醇(E_2)水平、获卵数、受精率、卵裂率、可移植胚胎数、妊娠率、种植率、流产率、卵巢过度刺激综合征(OHSS)发生率及促排卵药品的费用。结果三组患者Gn促排卵天数、HCG注射日E_2水平、获卵数、受精率、卵裂率、可移植胚胎数、妊娠率、种植率、流产率、OHSS发生率均无显著差异(P>0.05);uFSFH+HMG组Gn用量及费用显著少于其余两组(P<0.05)。结论 uFSH与rFSH超排卵效果相当,在IVF-ET长方案促排后期适当地加用HMG可取得更好的超排效果,且可降低患者的医药费用。 Objective: To compare the clinical efficacy and the cost-effectiveniss of in vitro fertilization embryo- transfer(IVF-ET)with three different protocols for controlled ovarian hyperstimulation. Methods: A total of 242 IVF/ICSI-ET cycles in infertility patients who received their treatment in our reproductive centre from January to November 2012 were analyzed retrospectively. They were divided into three groups according to ovarian stimulation protocol: rFSH group(gonal-F group, 102 patients), uFSH group (urofollitropin group, 82 patients) and uFSH + HMG group(urofollitropin+ HMG group, 58 patients). The clinical outcomes were compared among the three groups. Results: The duration of gonadotropin stimulation,estradiol levels on HCG day,numbers of retrieved oocytes, fertilization rate, the number of transferable embryos, clinical pregnancy rate, implantation rate, abortion rate and incidence of ovarian hyperstimulation syndrome were not significantly different among the three groups(P〈0.05). The total gonadotropin dose and the overall cost of gonadotropin in uFSH+HMG group were significantly less than those in the other two groups(P〈0.05). Conclusions: The u-FSH and r-FSH have the same effectiveness in ovarian stimulation in IVF-ET cycles. When u-FSH is used in combination with HMG,the clinical effectiveness is improved and the cost isreduced.
出处 《生殖医学杂志》 CAS 2013年第7期509-513,共5页 Journal of Reproductive Medicine
关键词 重组卵泡刺激素 尿源性卵泡刺激素 人绝经期促性腺激素 控制性促排卵 Recombinane follicle-stimulating hormone Urinary gonadotropi Controlled ovarian hyperstimulation.
  • 相关文献

参考文献8

  • 1Daya S. Follicle stimulating hormone in clinical practice: an update[J] Treat Endoerinol,2004,3:161-171.
  • 2Scobey MJ, Raike E, Marshall DC. Mixed protocols: multiple ratios of FSH and LH hioactivity using highly purified, human derived FSH (BRAVELLE)and highly purified hMG (MENOPUR)are unaltered by mixing together in the same syringe[J]. Reprod Biol Endocrinol, 2005,9 : 61-71.
  • 3夏红,张卫援.在超促排中应用不同促卵泡药物的疗效观察[J].山西医药杂志(上半月),2010,39(7):646-647. 被引量:1
  • 4Selman HA, De Santo M, Sterzik K, et al. Effect of highly purified urinary follicle-stimulating horm on eonoocyte and embryo quality[J]. Fertil Steril, 2002,78 : 1061 -1067.
  • 5徐仙,Rafael A.Cabrera,Benjamin C.Wong.基因重组/尿卵泡刺激素对卵巢的反应及辅助生殖技术结局的对比性研究[J].宁夏医学杂志,2005,27(10):651-654. 被引量:5
  • 6朱桂金.黄体生成素在卵泡发育中的作用和黄体生成素峰[J].生殖医学杂志,2007,16(5):312-313. 被引量:21
  • 7Drakakis P, Loutradis D, Kallianidis K, et al. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET[J]. Eur J Obstet Gynecol Reprod Biol, 2005,121:77-80.
  • 8Filicori M,Cognigni GE. Clinical review 126:roles and novel regimens of /uteinizing hormone and follicle stimulating hormone in ovulation induction[J]. J Clin Endocrinol Metab, 2001,86:1437 -1441.

二级参考文献16

  • 1Payne D.Intracytoplasmic sperm injection:instrumentation and injection technique.Reprod Fertil Dev,1995,7:185.
  • 2Keene JL,Matzuk MM,Otani T,et al.Expression of biologically active human follitropin in Chinese hamster ovary cells.J Biol Chem.1989,264(9):4769-4775.
  • 3Selman HA,De Santo M,Sterzik K,et al.Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.Fertil Steril.2002,78(5):1061-1067.
  • 4Munne S,Alikani M,Tomkin G,et al.Embryo Morphology developmental rate and maternal age are correlated with chromosoml abnormalities.Fertil Stril,1995,64(2):382-391.
  • 5Balasch J, Fabregues F, Creus M, et al. Pure and highly purified follicle - stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in invitro fertilization[J]. Hum Reprod, 1996, 11:2400 - 2404.
  • 6El - Shawarby SA, Turner CF, Reddy N, et al. Pregnancy following monofollicular ovulation induction with recombinant FSH, recombinant LH and timed coitus in an amenortheic woman with long- standing hypogonadotrophic hypogonadism[J]. BJOG, 2004, 111:1481 - 1484.
  • 7Recombinant Human FSH Study Group. Clinical assessment of recombinant human follicle - stimulating hormone in stimulating ovarian follicular development before in vitro fertilization [J]. Fertil Steril, 1998, 69(suppl 2) :50S- 58S.
  • 8Out HJ, Mannaerts BJ, Driessen SG, et al. A prospective, randomized, assessor- blind, multicenter study comparing recombinant and rinary follicle stimulating hormone in in - vitro fertilization [J]. Hum Reprod,1995, 10:2534 - 2540.
  • 9Bergh C, Howles CM, Borg K, et al. Recombinant human follicle stimulating hormone results of a randomized comparative study in women undergoing assisted reproductive techniques [ J ]. Hum Reprod, 1997, 12:2133 - 2139.
  • 10Faber BM, Mayer J, Cox B, et al. Cessation of gonadotropin - releasing hormone agonist therapy combined with high - dose gonadotropin stimulation yields favorable pregnancy results in low responders [J]. Fertil Steril, 1998, 69:826 - 830.

共引文献24

同被引文献25

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部